Sarasota, FL (PRWEB) August 19, 2009
Prostate brachytherapy (radioactive seed implantation) was demonstrated by Dr. Michael Dattoli, founder and physician-in-chief of the Dattoli Cancer Center & Brachytherapy Research Institute in Sarasota, FL in a TV broadcast from WBBH-TV NBC-2 from Fort Myers, FL on August 13, 2009.
Brachytherapy is a state-of-the-art prostate cancer treatment procedure that involves implanting tiny radioactive sources (seeds) into the prostate gland. The seeds emit a measured amount of precisely focused radiation over time to kill cancer cells. Dattoli uses brachytherapy in conjunction with daily sophisticated 4D-Image Guided Intensity Modulated Radiation Therapy, with Dynamic Adaptive RadioTherapy (4D-IG IMRT with DART) in the treatment of prostate cancer. These advanced forms of radiotherapy are non-invasive with minimal side effects compared to radical surgery and other forms of treatment.
Dr. Dattoli's innovative combination therapy has resulted in the world's longest, most successful treatment protocol for prostate cancer, as reported in February 2009 at the American Society for Clinical Oncology meeting. The Dattoli team's 16-year study stands as the longest published "cure rate" study in the world. The study, following men with high-risk prostate cancer, reveals a cure rate of 82% after 16 years of follow-up, superior to any other type of treatment currently available.
In the television broadcast, Cape Coral, Florida City Council member Bill Deile received 69 seeds in the 25-minute procedure performed at Sarasota Memorial Hospital as an outpatient. Deile, who was diagnosed with advanced prostate cancer earlier this year, has shared his experience through interviews and a blog on the TV station's website. Deile wanted to educate other men about the disease and the treatment option he chose. He has continued to work throughout his treatment, attending the City Council's regularly scheduled meeting on Monday, August 17.
Michael J. Dattoli, MD, is the author of a number of textbooks, articles, papers, booklets and the recently published Blue Ribbon Prostate Cancer Solution, (available from Amazon.com). This patient guide book evaluates all currently available, mainstream treatment options for this disease, as well as presenting Dattoli's 16-year study results.
The NBC broadcast can be viewed at: http://www.nbc-2.com/Global/story.asp?S=10926575
Details on the study and information on all publications are available on the website: http://www.dattoli.com.
DATTOLI CANCER CENTER
2803 Fruitville Road - Sarasota, Florida 34237